Identification of a costimulatory molecule-based signature to predict prognostic risk of pancreatic adenocarcinoma

Chao Wua Department of Oncology, Chinese PLA General Hospital, Beijing, People’s Republic of China

Jingyue Yangb Department of Oncology, Xijing Hospital, Air Force Military Medical University, Xi’an, People’s Republic of China

Rui Dingc Department of Hepatobiliary Surgery, Xijing Hospital, Air Force Military Medical University, Xi’an, People’s Republic of China

Xiao Lic Department of Hepatobiliary Surgery, Xijing Hospital, Air Force Military Medical University, Xi’an, People’s Republic of China

https://orcid.org/0000-0003-1731-7488

Zhi Yangd The IVD Medical Marketing Department, 3D Medicines Inc., Shanghai, People’s Republic of China

Min Zhue Department of Oncology, The Fifth medical center, Chinese PLA General Hospital, Beijing, People’s Republic of ChinaCorrespondence[email protected] [email protected]

Zhengcai Liuf Department of Hepatopancreatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, People’s Republic of ChinaCorrespondence[email protected] [email protected]

show all

Identification of a costimulatory molecule-based signature to predict prognostic risk of pancreatic adenocarcinoma

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Identification of a costimulatory molecule-based signature to predict prognostic risk of pancreatic adenocarcinoma

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date